Cambrex Announces $150 Million Expansion across U.S. and European Facilities
Introduction
Cambrex has revealed significant progress on its expansion initiatives across the United States and Europe. These projects are designed to boost capacity for manufacturing complex drugs and meet the rising demand for specialized pharmaceutical services.
Features:
U.S: A new large-scale API manufacturing facility will be constructed, featuring 140,000 liters of production capacity.
The site will include large- and mid-scale reactors, state-of-the-art Hastelloy agitated filter dryers, and upgrades to existing production suites.
Construction is planned to begin in late 2026.
European: Cambrex will enhance its Milan site with new analytical development and process R&D laboratories, along with upgrades to several existing production plants.
Additional land has been secured to allow for future growth. The expansion is expected to be completed during the latter half of 2027.
Specifications:
| Name | Cambrex |
| Budget | $150 Million |
| Type | Expansion |
